Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Response Biomed Corp RPBIF

"Response Biomedical Corp is engaged in the research, development, commercialization and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental testing markets."

GREY:RPBIF - Post Discussion

View:
Post by Hurting20 on Jan 09, 2015 12:57pm

geez

Man this is better than any tv comedy.
For all those happy with the new money in the RBM coffers I want to remind everyone, they raised a couple of  millions dollars, yes, nearly 40% was used for severance. 
Latest RBM news. One of the board members joined another board. 
Honestly could you make this up
Comment by yoshka2000 on Jun 02, 2015 1:35am
HURTING, is RBM an unofficial Golden Parachute Club for BOD's. Man, not much changed over the last 20 or more years. If this was done right way back when, then this would of been a $20.00 stock.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities